Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
Phys Med. 2021 Feb;82:269-278. doi: 10.1016/j.ejmp.2021.02.019. Epub 2021 Mar 8.
To determine the advantages of inverse planning using a prerelease version of Leksell Gamma Knife® (LGK) Lightning (Elekta AB, Sweden) compared to manual forward planning.
Thirty-eight patients with metastases (MET, n = 15), vestibular schwannomas (VS, n = 11) and meningiomas (MEN, n = 12), treated with LGK Icon™ at our institution, were analyzed retrospectively. For each case, an inverse (inv) and inverse full coverage (fc) treatment plan was generated using LGK Lightning and compared to the clinical plans. Several dosimetry and efficiency characteristics were compared for each indication. The mean, median difference and interquartile range were reported and the significance was assessed with a paired-sample Wilcoxon test (significance level < 0.05). Further, the inter operator variability was analyzed for multiple users.
Inv and fc treatment plans show improved target coverage (up to 3.6%) for all analyzed paradigms. For inv plans, the selectivity is enhanced (MET: 2.9%; VS: 1.8%; MEN: 1%) and the organ at risk doses are significantly reduced (VS: up to 4.5%; MEN: up to 17.5%). For inv and fc plans, the beam on time (BOT) is shortened (MET: up to 7.9%; benign tumors: 49.5%). The inter operator variability analysis shows similar treatment plan quality with small differences in plan efficiency (difference in BOT: 1-3.3 min).
LGK Lightning allows to generate improved LGK treatment plans regarding plan quality with reduced BOT compared to manual forward plans. The inter operator variability showed that multiple users with different experiences can generate similar treatment plan quality using LGK Lightning.
与手动正向计划相比,确定使用 Leksell Gamma Knife®(LGK)Lightning(Elekta AB,瑞典)预发布版本进行逆向计划的优势。
回顾性分析了在我院接受 LGK Icon™治疗的 38 例转移瘤(MET,n=15)、前庭神经鞘瘤(VS,n=11)和脑膜瘤(MEN,n=12)患者。对于每个病例,使用 LGK Lightning 生成逆向(inv)和逆向全覆盖(fc)治疗计划,并与临床计划进行比较。比较了每种适应症的几个剂量学和效率特征。报告了平均值、中位数差异和四分位间距,并使用配对样本 Wilcoxon 检验评估了显著性(显著性水平<0.05)。此外,还分析了多位操作人员的操作者间变异性。
inv 和 fc 治疗计划显示所有分析范例的靶区覆盖度均得到改善(高达 3.6%)。对于 inv 计划,选择性得到增强(MET:2.9%;VS:1.8%;MEN:1%),危及器官剂量显著降低(VS:高达 4.5%;MEN:高达 17.5%)。对于 inv 和 fc 计划,束流开启时间(BOT)缩短(MET:高达 7.9%;良性肿瘤:49.5%)。操作者间变异性分析显示,治疗计划质量相似,计划效率差异较小(BOT 差异:1-3.3 分钟)。
与手动正向计划相比,LGK Lightning 可生成改善的 LGK 治疗计划,在降低 BOT 的同时提高计划质量。操作者间变异性表明,具有不同经验的多位操作人员可以使用 LGK Lightning 生成相似的治疗计划质量。